KB-7CC7

Macro-3 S2 Owner Owner-Approval Question — R2-B2 (2026-06-19)

2 min read Revision 1
laws-newR2-B2macro-3S2ownerowner-approval-questionnon-authorizingowner-gated2026-06-19

Macro-3 S2 Owner Owner-Approval Question — R2-B2 (2026-06-19)

Date: 2026-06-19 · Workstream: R2-B2-MACRO-3-OPTION-D-OWNER-DELEGATE-DECISION-PACKAGE-2026-06-19 (Deliverable 23 of 60) · Editorial revision: rev1 Class: S2 owner-approval question · READ-ONLY · NON-ENACTING · NON-AUTHORIZING · OWNER_APPROVAL_REQUIRED · NO write performed.

Metadata convention. Editorial revision (rev1) only. Storage revision/content_length authoritative at read time.


0. Status and non-authorization

STATUS: PASS — engineering / decision-prep. Poses the S2 decision to the Owner; does not answer it. Engineering PASS ≠ authority PASS. Default: HOLD.

1. Purpose

Give the Owner one precise question whose answer is the S2 owner decision.

2. Sources / evidence read

D16–D22. Main process, no reader-agents.

3. Accepted baseline (carried)

Recommendation: dedicated B2 Producer Owner role/class (M-3); Điều 37→32; no self-approve.

4. Evidence / analysis

G-5 (owner) is open and non-waivable; governance_object_ownership=0.

5. Recommendation / matrix / result — the questions

S2-Q1: Do you adopt a single accountable B2 Producer Owner role (M-3: single owner + Điều-32 council review), as opposed to a committee or an ad-hoc person? — Default: HOLD. S2-Q2: Who holds the role? — Default: HOLD (unnamed); assignment requires SP-1…SP-7. S2-Q3: Do you authorize the Điều 37→32 process to begin gathering SP-evidence? (still no row written) — Default: HOLD.

6. Owner-gated future work

Answering S2-Q1…Q3, then SP-evidence, then the row write — all Owner acts; forbidden now.

7. What remains unresolved

All three unanswered; no owner.

8. Ready for GPT/Codex review

Yes — Codex should confirm the questions are answerable and the defaults are safe (HOLD).

Back to Knowledge Hub knowledge/dev/laws-new/newlaws/consolidation/macro3-s2-owner-owner-approval-question-r2-b2-2026-06-19.md